McKesson Bets Another $2.25B on Cancer Care With Precision Medicine Buy
The healthcare giant is doubling down on oncology, betting that targeted therapies and data will reshape how cancer drugs reach patients.
By Khalid Al-Harbi·· 3 min

Loading the Newsroom
Curating from trusted global sources…
1 briefing · “mckesson”
The healthcare giant is doubling down on oncology, betting that targeted therapies and data will reshape how cancer drugs reach patients.